0001461993-17-000005.txt : 20171120 0001461993-17-000005.hdr.sgml : 20171120 20171120171356 ACCESSION NUMBER: 0001461993-17-000005 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20171120 DATE AS OF CHANGE: 20171120 EFFECTIVENESS DATE: 20171120 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MELINTA THERAPEUTICS, INC. /NEW/ CENTRAL INDEX KEY: 0001461993 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 454440364 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-299206 FILM NUMBER: 171214579 BUSINESS ADDRESS: STREET 1: 6320 QUADRANGLE DRIVE STREET 2: SUITE 360 CITY: CHAPEL HILL STATE: NC ZIP: 27517-8149 BUSINESS PHONE: 919-576-2306 MAIL ADDRESS: STREET 1: 6320 QUADRANGLE DRIVE STREET 2: SUITE 360 CITY: CHAPEL HILL STATE: NC ZIP: 27517-8149 FORMER COMPANY: FORMER CONFORMED NAME: CEMPRA, INC. DATE OF NAME CHANGE: 20120203 FORMER COMPANY: FORMER CONFORMED NAME: Cempra Holdings, LLC DATE OF NAME CHANGE: 20090414 D 1 primary_doc.xml X0708 D LIVE 0001461993 MELINTA THERAPEUTICS, INC. /NEW/ 300 George Street, Suite 301 New Haven CT CONNECTICUT 06511 312-767-0291 DELAWARE CEMPRA, INC. Cempra Holdings, LLC Corporation true Daniel Wechsler 300 George Street, Suite 301 New Haven CT CONNECTICUT 06511 Executive Officer Director Director, President and Chief Executive Officer Jay Galeota 300 George Street, Suite 301 New Haven CT CONNECTICUT 06511 Director David Gill 300 George Street, Suite 301 New Haven CT CONNECTICUT 06511 Director Cecilia Gonzalo 300 George Street, Suite 301 New Haven CT CONNECTICUT 06511 Director John Johnson 300 George Street, Suite 301 New Haven CT CONNECTICUT 06511 Director Thomas P. Koestler 300 George Street, Suite 301 New Haven CT CONNECTICUT 06511 Director Garheng Kong 300 George Street, Suite 301 New Haven CT CONNECTICUT 06511 Director David Zaccardelli 300 George Street, Suite 301 New Haven CT CONNECTICUT 06511 Director Kevin Ferro 300 George Street, Suite 301 New Haven CT CONNECTICUT 06511 Director Paul Estrem 300 George Street, Suite 301 New Haven CT CONNECTICUT 06511 Executive Officer Executive Vice President, Chief Financial Officer and Secretary John Temperato 300 George Street, Suite 301 New Haven CT CONNECTICUT 06511 Executive Officer Executive Vice President and Chief Commercial Officer Sue Cammarata 300 George Street, Suite 301 New Haven CT CONNECTICUT 06511 Executive Officer Executive Vice President and Chief Medical Officer Erin Duffy 300 George Street, Suite 301 New Haven CT CONNECTICUT 06511 Executive Officer Executive Vice President and Chief Scientific Officer Pharmaceuticals Decline to Disclose 06b false 2017-11-03 false true true Stock-for-stock merger 0 132914810 132914810 0 false 39 0 0 0 No cash proceeds will be received by the Issuer in connection with the offering. Consideration for Issuer's issued shares is shares of Melinta Subsidiary Corp (f/k/a Melinta Therapeutics, Inc.) false MELINTA THERAPEUTICS, INC. /NEW/ Paul Estrem Paul Estrem See Clarification Box in Item # 3 2017-11-20